ArticleArthritis & rheumatology (Hoboken, N.J.)2021

The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model.

Anthony D Marinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.